Oscient Pharmaceuticals Corporation Receives NASDAQ Letter Regarding Delay in Filing Form 10-Q

Published: May 26, 2009

WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) has received notification from the Listings Qualifications Department of The NASDAQ Stock Market LLC that since the Company has not filed its Form 10-Q for the period ended March 31, 2009, the Company is no longer in compliance with Marketplace Rule 5250(c)(1).

Back to news